Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens' (WBA) subsidiary teams up with Buckeye Health Plan to provide wellness services through Walgreens Health Corner locations in Ohio.

Walgreens (WBA) to Offer Health Services to Ohio Medicaid Members

CVS Health

Walgreens Boots Alliance and CVS Health shares had a tendency in the past to move somewhat closely with each other (on a daily percentage basis). More recently, Walgreens and CVS stocks show a divergence from each other.

Buy Walgreens And Sell CVS: A Pair Trade Idea

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Health – a division of Walgreens Boots Alliance, Inc. that develops consumer-centric, technology-enabled healthcare solutions – today announced a new collaboration with Buckeye Health Plan to bring innovative health and wellness services to Medicaid members in five northeast Ohio neighborhood locations this summer. Buckeye Health Plan, an Ohio managed care company, is the third payer to partner with Walgreens Health to launch Walgreens Health Corner™

Walgreens Health Collaborates with Buckeye Health Plan to Expand Local Access to Health and Wellness Services

Walgreens Boots (WBA) continues to serve communities with COVID testing and vaccinations to fight the pandemic.

Walgreens (WBA) Starts COVID Jabs for 3-Year Olds & Above

DEERFIELD, Ill.--(BUSINESS WIRE)--Appointments for toddlers will be available beginning Saturday, June 25, and can be scheduled now at Walgreens.com/ScheduleVaccine.

Walgreens Now Providing Pfizer and Moderna COVID-19 Vaccines to Children Ages 3 and Older at Select Locations Nationwide

Franklin Resources

Community Trust Bancorp

Emerson Electric

Leggett & Platt

Medtronic

Old Republic International

Sonoco Products

Stanley Black & Decker

Telephone and Data Systems

Target

United Bankshares

Universal Corp

Exxon Mobil

Drip Investing lists over 800 stocks that have annually increased dividends for 5 years or more. As of June, 62 stocks have hiked their dividends annually 40 years or more. Parsed from 129 Champions, utilizing YCharts-data as of 6/16/22, those 62 select-dividend stocks ranged 0.93% to 5.66% in annual yield, and ranged -0.97% to 55.33% in analyst 1-yr price-target upsides.

40Yr+Dividend Growers Sprout 8 Buys In June

Chevron

Intel

JPMorgan Chase & Co

Coca-Cola

Merck

Walmart

If you only have $250 to spend, here are the best Dow stocks to buy based on the current macroeconomic dynamics. The post The 7 Smartest Dow Stocks to Buy if You Have $250 Right Now appeared first on InvestorPlace.

The 7 Smartest Dow Stocks to Buy if You Have $250 Right Now

Walgreens Boots Alliance Inc. WBA, +1.32% said Thursday it is launching a clinical trial business to help address the problems of access and diversity in the industry. The move comes after recent steps by the U.S. Food and Drug Administration to increase the racial and ethnic diversity of participants in clinical trials, as about 20% of drugs have a variation in response across ethnic groups, even though trials tend to skew predominantly white.

Walgreens launches clinical trial business with the aim of improving diversity of participants

Walgreens Boots Alliance Inc on Thursday launched a clinical trials business that aims to use patient data from its pharmacies to help drive up recruitment in studies conducted by drugmakers.

Walgreens enters clinical trials business through new unit

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens today announced the launch of its clinical trial business to redefine the patient experience and increase access and retention in sponsor-led drug development research. Walgreens flexible clinical trial model combines the company's vast foundation of patient insights, partner-enabled health and technology capabilities and in-person and virtual care options to break through barriers to engaging broader and more diverse communities. The introduction of

Walgreens Launches Clinical Trial Business to Address Industrywide Access and Diversity Challenges and Redefine Patient Experience

Walgreens is launching a clinical trial business to increase racial and ethnic diversity for patients in drug research.

Walgreens Launches Clinical Trial Business As FDA Seeks Diversity Of Patients

DEERFIELD, Ill. & SAN FRANCISCO--(BUSINESS WIRE)--Walgreens and Greater Than AIDS, a public information initiative of KFF (Kaiser Family Foundation), are teaming up with health departments and community organizations in more than 250 cities to host the largest coordinated National HIV Testing Day (NHTD) event in the nation. Click here for a list of participating Walgreens stores and hours to get a free HIV test on Monday, June 27. “The last two years of COVID-19 saw declines in HIV testing, and

Walgreens and Greater Than AIDS Partner with Health Departments and Community Organizations to Provide Free HIV Testing and Information in More Than 250 Cities on National HIV Testing Day (June 27)

Cisco Systems

Goldman Sachs

Travelers

Undervalued Dow stocks can be difficult to find, but this article is looking at seven that investors should consider buying right now. The post 7 Seriously Undervalued Dow Stocks to Buy Before Wall Street Catches On appeared first on InvestorPlace.

7 Seriously Undervalued Dow Stocks to Buy Before Wall Street Catches On

I value WBA $36.93 and can sell put options at $37 to potentially establish a potential long-term position. WBA is a strong historical performer that has the future opportunity to reignite its growth.

Walgreens Boots Alliance: Resetting For A Comeback

BHP Billiton

Blackrock Inc

McDonald's

NextEra Energy

Verizon

Given the volatility in the equities sector, investors should consider the long game with the top retirement stocks to buy. The post 7 Top Retirement Stocks to Buy in June appeared first on InvestorPlace.

7 Top Retirement Stocks to Buy in June

Walgreens Boots Alliance Inc (NASDAQ:WBA) has reportedly received a formal offer for its Boots business from Reliance Industries and Apollo Global Management (NYSE:APO). Reliance, owned by Indian billionaire Mukesh Ambani, has teamed up with the US private equity fund to lodge a £5bn bid for the UK chain of chemists, which was acquired by the US company in 2012.

Walgreens Boots Alliance reportedly finds a buyer for Boots

Boeing

Disney

General Electric

These blue-chip stocks to sell, once titans in their respective sectors, have fallen on hard times and shareholders have suffered as a result. The post 7 Dying Blue-Chip Stocks to Sell While You Still Can appeared first on InvestorPlace.

7 Dying Blue-Chip Stocks to Sell While You Still Can

A consortium comprised of Apollo Global Management APO, -2.98% and Reliance Industries Ltd. 500325, +2.73% has made a binding offer for the international arm of Walgreens Boots Alliance Inc. WBA, -0.93% , Bloomberg reported Thursday, citing people with knowledge of the matter.

Apollo and Reliance Industries have made binding offer for Walgreens international arm: Bloomberg

PORTLAND, Ore.--(BUSINESS WIRE)--Wile, a hormonal wellness brand for women 40+, announced today it will debut four of its capsule skus in Walgreens this month. Established in 2021, Wile offers clinically backed supplements made with unique herbal and plant formulas, created in partnership with naturopathic doctors and research scientists. Headquartered in Portland, OR, Wile is led by co-founders Gwen Floyd, Corey Scholibo, and Julie Kucinski alongside actress and activist Judy Greer. “As a bran

Wile Launches Hormonal Wellness Capsules in Walgreens Nationwide

The price multiples of Walgreens are very low, and through a discounted cash flow I calculated a fair value of $78.42, well above the current $43. Walgreens management has realized that the company needs a jolt to improve its growth rates, and over the past year has decided to invest heavily in the health care sector.

Walgreens: Fair Value Well Above Current Price

Brookfield Infrastructure Partners L.P.

EPR Properties

Foot Locker

Kraft Heinz

Kinder Morgan

Viatris

These are the best dividend stocks with high yields to invest in now. BIP, EPR, FL, KMI, KHC, VTRS, and WBA can make great investments.

7 High-Quality Dividend Stocks With High Yields

New year, new world. That could sum up 2022, but it's a bit more involved.

Walgreens Taps Digital Payments and Data to Reinvent the Customer Journey

Walgreens Boots Alliance sale of its Boots pharmacies in the United Kingdom is apparently near if the latest media reports out of London and India are correct.

Is Walgreens Sale Of Boots U.K. Boots Pharmacies Finally Near?

American Eagle Outfitters

AGNC Investment

4 Ultra-Cheap, Time-Tested Stocks That Can Turn $300,000 Into $1 Million by 2030

WBA has a large debt load that could put dividend at risk. Recent attempts to sell Boots seem to have stalled.

News for Walgreens Stock (WBA)